|
显示项目 392511-392520 / 2348973 (共234898页)
<< < 39247 39248 39249 39250 39251 39252 39253 39254 39255 39256 > >>
每页显示[10|25|50]项目
| 國立成功大學 |
2006-07 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
De Man, R. A.; Mutimer, D.; Gish, R.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
| 國立成功大學 |
2006-10 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
Sollano, J.; De Man, R. A.; Mutimer, D.; Gish, R. G.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
| 國立成功大學 |
2006-03 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
Chang, Ting-Tsung; Chao, You-Chen; Sollano, Jose; Han, Kwang-Hyub; Lai, Ching-Lung; Lao-Tan, Judy; Akbar, Nurul; Zhu, Jin; Cross, Anne; Brett-Smith, Helena; Neo, Boon-Leong |
| 國立成功大學 |
2006-10 |
Entecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027)
|
Akarca, U.; Hatzis, G.; Kitis, G.; Shouval, D.; Lai, C.; Cheinquer, H.; Chang, Ting-Tsung; Zink, R.; Zhu, J.; Brett-Smith, H. |
| 國立成功大學 |
2012-09 |
Entecavir efficacy and safety in patients >= 50 years of age
|
Sievert, W.; Wedemeyer, H.; Gish, R.; Nguyen, T.; Lai, C. L.; Llamoso, C.; Chang, T. T. |
| 國立成功大學 |
2006-10-27 |
ENTECAVIR MAINTAINED VIROLOGIC SUPPRESSION THROUGH 3 YEARS OF TREATMENT IN ANTIVIRALNAı‥VE HBEAG PATIENTS (ETV 022/901)
|
Chang, Ting-Tsung; Chao, You-Chen; Sabahattin Kaymakoglu; Hugo Cheinquer; Mario Pessoa; Robert Gish; Fred Poordad; Yang, Joanna; Helena Brett-Smith; Robert Hindes |
| 國立臺灣大學 |
2013 |
ENTECAVIR PLUS PEGINTERFERON alfa-2a vs. ENTECAVIR ALONE IN THE TREATMENT OF HEPATITIS B e ANTIGEN-POSITIVE CHRONIC HEPATITIS B: AN INTERIM REPORT
|
Liu, C. -J.; Wang, C. -C.; Yang, S. -S.; Su, C. -W.; Liao, L. -Y.; Lee, T. -H.; Chuang, W. -L.; Chen, C. -L.; Chien, R. -N.; Peng, C. -Y.; Lee, C. -M.; Lee, Y. -F.; Kao, J. -H.; Chen, P. -J.; Chen, D. -S.; 劉俊人 |
| 臺大學術典藏 |
2022-01-24T09:30:51Z |
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
|
Cheng P.-N.; CHUN-JEN LIU; Chen C.-Y.; Tseng K.-C.; Lo C.-C.; Peng C.-Y.; Lin C.-L.; Chiu H.-C.; Chiu Y.-C.; Chen P.-J. |
| 臺大學術典藏 |
2022-02-14T23:55:40Z |
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
|
Cheng, Pin Nan; CHUN-JEN LIU; Chen, Chi Yi; Tseng, Kuo Chih; Lo, Ching Chu; Peng, Cheng Yuan; Lin, Chih Lin; Chiu, Hung Chih; Chiu, Yen Cheng; PEI-JER CHEN |
| 國立成功大學 |
2022-12 |
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
|
Cheng;Pin-Nan;Liu;Chun-Jen;Chen;Chi-Yi;Tseng;Kuo-Chih;Lo;Ching-Chu;Peng;Cheng-Yuan;Lin;Chih-Lin;Chiu;Hung-Chih;Chiu;Yen-Cheng;Chen;Pei-Jer |
显示项目 392511-392520 / 2348973 (共234898页)
<< < 39247 39248 39249 39250 39251 39252 39253 39254 39255 39256 > >>
每页显示[10|25|50]项目
|
